Get the Stockscreener App
17.45
3.25%
0.55
After Hours:
17.47
0.02
+0.11%
Mediwound Ltd stock is traded at $17.45, with a volume of 65,250.
It is up +3.25% in the last 24 hours and down -0.17% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$16.90
Open:
$16.8
24h Volume:
65,250
Relative Volume:
1.46
Market Cap:
$189.04M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-7.1811
EPS:
-2.43
Net Cash Flow:
$-21.94M
1W Performance:
+3.99%
1M Performance:
-0.17%
6M Performance:
+6.47%
1Y Performance:
+103.86%
1-Day Range:
$16.77
$17.62
1-Week Range:
$16.30
$17.62
52-Week Range:
$8.48
$24.00
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.45 | 189.04M | 19.85M | -12.75M | -21.94M | -2.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
MediWound (NASDAQ:MDWD) Given New $25.00 Price Target at HC Wainwright - MarketBeat
MediWound Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
MediWound Advances Enzymatic Therapeutics Amid Financial Shifts - TipRanks
Mediwound earnings missed by $0.53, revenue fell short of estimates - Investing.com Australia
MediWound: Q3 Earnings Snapshot - New Haven Register
Earnings call: MediWound shows progress in Q3 with FDA nod for NexoBrid - Investing.com
MediWound Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewswire
MediWound Q3 Revenue Falls to $4.4M Despite NexoBrid FDA Approval; Cuts 2024 Guidance | MDWD Stock News - StockTitan
What To Expect From MediWound Ltd (MDWD) Q3 2024 Earnings - GuruFocus.com
Where are the Opportunities in (MDWD) - Stock Traders Daily
MediWound (MDWD) to Release Earnings on Tuesday - Defense World
MediWound Ltd.'s (NASDAQ:MDWD) institutional investors lost 10% last week but have benefitted from longer-term gains - Simply Wall St
MediWound to Discuss New Share Incentive Plan - TipRanks
MediWound to Report Third Quarter 2024 Financial Results - GlobeNewswire
MediWound Q3 2024 Earnings Call Scheduled for November 26: What to Expect | MDWD Stock News - StockTitan
99,994 Shares in MediWound Ltd. (NASDAQ:MDWD) Bought by ARK Investment Management LLC - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) is Rosalind Advisors Inc.'s 5th Largest Position - MarketBeat
MediWound (STU:M8W) Financial Strength : 6 (As of Jun. 2024) - GuruFocus.com
How the (MDWD) price action is used to our Advantage - Stock Traders Daily
MediWound Is A Healthy Investment (NASDAQ:MDWD) - Seeking Alpha
MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year - Yahoo Finance UK
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd - Yahoo Finance
(MDWD) Pivots Trading Plans and Risk Controls - Stock Traders Daily
MediWound (NASDAQ:MDWD) Rating Reiterated by HC Wainwright - Defense World
Trading (MDWD) With Integrated Risk Controls - Stock Traders Daily
MediWound shares maintain buy rating on new study plans - Investing.com India
MediWound shares maintain buy rating on new study plans By Investing.com - Investing.com South Africa
MediWound (NASDAQ:MDWD) Earns Buy Rating from HC Wainwright - MarketBeat
MediWound advances EscharEx in Phase II VLU study By Investing.com - Investing.com Australia
MediWound advances EscharEx in Phase II VLU study - Investing.com India
MediWound Announces Phase II Head-to-Head Study Evaluating - GlobeNewswire
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
(MDWD) On The My Stocks Page - Stock Traders Daily
Rhumbline Advisers Purchases Shares of 8,440 MediWound Ltd. (NASDAQ:MDWD) - Defense World
Objective long/short (MDWD) Report - Stock Traders Daily
TD Cowen maintains Buy rating on MediWound shares with no price target change - Investing.com
MediWound (NASDAQ:MDWD) Stock Price Crosses Below 200-Day Moving Average of $16.99 - MarketBeat
(MDWD) Long Term Investment Analysis - Stock Traders Daily
MediWound (NASDAQ:MDWD) Shares Cross Above 50 Day Moving Average of $18.20 - MarketBeat
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):